Consumer Fraud Articles
Harvard Medical School to stand trial for Alzheimer’s research fraud
Harvard Medical School will face trial for conducting research fraud after a U.S. Appeals Court overturned the decision of a lower court Tuesday and ordered the case to proceed. The claim, which involves one of the largest Alzheimer’s disease research
Abbott to pay $1.5 billion for illegally promoting Depakote, thanks to whistleblower lawsuits
Abbott Laboratories has pleaded guilty and agreed to pay $1.5 billion to resolve criminal and civil charges for fraudulently promoting its anti-seizure drug Depakote for a number of unapproved, off-label purposes. The near-record payout, the second largest by a drug
Montgomery man faces harsh backlash after blowing whistle on his international employer
MONTGOMERY, ALA–Blowing the whistle on corporate fraud and other wrongdoing would be a no-brainer for most people, but the truth is workers have a lot to consider when faced with the prospect of calling out their employers. The threat of
Actos linked to serious psychiatric impairments, medical reviewer alleges
The diabetes drug Actos is linked to higher rates of suicide, schizophrenia, epilepsy, and grand mal seizures compared to other drugs in the same class, such as Avandia, says Dr. Helen Ge, a former medical reviewer in Takeda Pharmaceuticals’ pharmacovigilance
Unnecessary surgeries were performed for profit and promotion, whistleblower lawsuit alleges
A whistleblower lawsuit filed against The University of Pittsburgh Medical Center’s (UPMC) Hamot campus under the False Claims Act accuses the hospital and five cardiologists of defrauding Medicare and a number of patients by participating in a kickback scheme from
Whistleblower receives $21 million for exposing health care fraud
A former senior financial analyst for a Florida-based health plan provider will receive nearly $21 million for his role in exposing his employer’s fraudulent business practices, which involved double billing Medicare and Medicaid.
“Reluctant whistleblower” tells Reuters about pink slime in ground beef
The national outrage over chemically treated meat scraps dubbed “pink slime” and sold to unsuspecting consumers as ground beef started with a disapproving email written by a U.S. Department of Agriculture (USDA) microbiologist to a colleague.
Toyota can’t force arbitration in sudden unintended acceleration cases, judge rules
Toyota can’t force arbitration of economic-loss claims filed by plaintiffs who allege the carmaker’s sudden-unintended-acceleration defects led to diminished market value for their vehicles, U.S. District judge James Selna has ruled.
Whistleblowers key in the fight against fraud
Whistleblowers have become one of the federal government’s most valuable tools in its ongoing efforts to crack down on corporate wrongdoing and recover money lost to overbilling and other fraudulent activities.